Global Liposome Technology Service Market Research Report 2025

Publication ID:

PB505251615

Publication Date:

May 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Liposome Technology Service was valued at US$ 1511 million in the year 2024 and is projected to reach a revised size of US$ 2075 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Liposome technology services refer to the professional technology that provides a series of services such as liposome preparation, optimization, drug encapsulation and evaluation. These services are mainly used in the fields of drug delivery, gene delivery, vaccine delivery and other fields to improve the bioavailability and targeting of drugs and reduce side effects and toxicity.
The application of liposomes as anti-tumor drug carriers is an important development trend. As drug carriers, liposomes can protect drugs from destruction by organisms, while improving the bioavailability and targeting of drugs and reducing side effects and toxicity. In the field of tumor treatment, liposomes are increasingly used and have become an important direction in anti-tumor drug research.
This report aims to provide a comprehensive presentation of the global market for Liposome Technology Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Technology Service.
The Liposome Technology Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Technology Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Technology Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LIPOSOMA
CD Formulation
Creative Biostruct
Echelon Biosciences
Encapsula Nanosciences
Toshiba
FUJIFILM Pharmaceuticals USA
Lifeasible
PlantaCorp
LIPOMIZE SRL
Maison KOS脡
Microfluidics International Corporation
Exelead
Segment by Type
Liposome Production Services
Liposome Analysis and Characterization Services
Liposome Drug Delivery System Development Services
Others
Segment by Application
Cancer Treatment
Gene Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Technology Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Technology Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposome Production Services
1.2.3 Liposome Analysis and Characterization Services
1.2.4 Liposome Drug Delivery System Development Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Technology Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Treatment
1.3.3 Gene Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Technology Service Market Perspective (2020-2031)
2.2 Global Liposome Technology Service Growth Trends by Region
2.2.1 Global Liposome Technology Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposome Technology Service Historic Market Size by Region (2020-2025)
2.2.3 Liposome Technology Service Forecasted Market Size by Region (2026-2031)
2.3 Liposome Technology Service Market Dynamics
2.3.1 Liposome Technology Service Industry Trends
2.3.2 Liposome Technology Service Market Drivers
2.3.3 Liposome Technology Service Market Challenges
2.3.4 Liposome Technology Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposome Technology Service Players by Revenue
3.1.1 Global Top Liposome Technology Service Players by Revenue (2020-2025)
3.1.2 Global Liposome Technology Service Revenue Market Share by Players (2020-2025)
3.2 Global Liposome Technology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposome Technology Service Revenue
3.4 Global Liposome Technology Service Market Concentration Ratio
3.4.1 Global Liposome Technology Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Technology Service Revenue in 2024
3.5 Global Key Players of Liposome Technology Service Head office and Area Served
3.6 Global Key Players of Liposome Technology Service, Product and Application
3.7 Global Key Players of Liposome Technology Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Technology Service Breakdown Data by Type
4.1 Global Liposome Technology Service Historic Market Size by Type (2020-2025)
4.2 Global Liposome Technology Service Forecasted Market Size by Type (2026-2031)
5 Liposome Technology Service Breakdown Data by Application
5.1 Global Liposome Technology Service Historic Market Size by Application (2020-2025)
5.2 Global Liposome Technology Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposome Technology Service Market Size (2020-2031)
6.2 North America Liposome Technology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposome Technology Service Market Size by Country (2020-2025)
6.4 North America Liposome Technology Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposome Technology Service Market Size (2020-2031)
7.2 Europe Liposome Technology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposome Technology Service Market Size by Country (2020-2025)
7.4 Europe Liposome Technology Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposome Technology Service Market Size (2020-2031)
8.2 Asia-Pacific Liposome Technology Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposome Technology Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposome Technology Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposome Technology Service Market Size (2020-2031)
9.2 Latin America Liposome Technology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposome Technology Service Market Size by Country (2020-2025)
9.4 Latin America Liposome Technology Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposome Technology Service Market Size (2020-2031)
10.2 Middle East & Africa Liposome Technology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposome Technology Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposome Technology Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LIPOSOMA
11.1.1 LIPOSOMA Company Details
11.1.2 LIPOSOMA Business Overview
11.1.3 LIPOSOMA Liposome Technology Service Introduction
11.1.4 LIPOSOMA Revenue in Liposome Technology Service Business (2020-2025)
11.1.5 LIPOSOMA Recent Development
11.2 CD Formulation
11.2.1 CD Formulation Company Details
11.2.2 CD Formulation Business Overview
11.2.3 CD Formulation Liposome Technology Service Introduction
11.2.4 CD Formulation Revenue in Liposome Technology Service Business (2020-2025)
11.2.5 CD Formulation Recent Development
11.3 Creative Biostruct
11.3.1 Creative Biostruct Company Details
11.3.2 Creative Biostruct Business Overview
11.3.3 Creative Biostruct Liposome Technology Service Introduction
11.3.4 Creative Biostruct Revenue in Liposome Technology Service Business (2020-2025)
11.3.5 Creative Biostruct Recent Development
11.4 Echelon Biosciences
11.4.1 Echelon Biosciences Company Details
11.4.2 Echelon Biosciences Business Overview
11.4.3 Echelon Biosciences Liposome Technology Service Introduction
11.4.4 Echelon Biosciences Revenue in Liposome Technology Service Business (2020-2025)
11.4.5 Echelon Biosciences Recent Development
11.5 Encapsula Nanosciences
11.5.1 Encapsula Nanosciences Company Details
11.5.2 Encapsula Nanosciences Business Overview
11.5.3 Encapsula Nanosciences Liposome Technology Service Introduction
11.5.4 Encapsula Nanosciences Revenue in Liposome Technology Service Business (2020-2025)
11.5.5 Encapsula Nanosciences Recent Development
11.6 Toshiba
11.6.1 Toshiba Company Details
11.6.2 Toshiba Business Overview
11.6.3 Toshiba Liposome Technology Service Introduction
11.6.4 Toshiba Revenue in Liposome Technology Service Business (2020-2025)
11.6.5 Toshiba Recent Development
11.7 FUJIFILM Pharmaceuticals USA
11.7.1 FUJIFILM Pharmaceuticals USA Company Details
11.7.2 FUJIFILM Pharmaceuticals USA Business Overview
11.7.3 FUJIFILM Pharmaceuticals USA Liposome Technology Service Introduction
11.7.4 FUJIFILM Pharmaceuticals USA Revenue in Liposome Technology Service Business (2020-2025)
11.7.5 FUJIFILM Pharmaceuticals USA Recent Development
11.8 Lifeasible
11.8.1 Lifeasible Company Details
11.8.2 Lifeasible Business Overview
11.8.3 Lifeasible Liposome Technology Service Introduction
11.8.4 Lifeasible Revenue in Liposome Technology Service Business (2020-2025)
11.8.5 Lifeasible Recent Development
11.9 PlantaCorp
11.9.1 PlantaCorp Company Details
11.9.2 PlantaCorp Business Overview
11.9.3 PlantaCorp Liposome Technology Service Introduction
11.9.4 PlantaCorp Revenue in Liposome Technology Service Business (2020-2025)
11.9.5 PlantaCorp Recent Development
11.10 LIPOMIZE SRL
11.10.1 LIPOMIZE SRL Company Details
11.10.2 LIPOMIZE SRL Business Overview
11.10.3 LIPOMIZE SRL Liposome Technology Service Introduction
11.10.4 LIPOMIZE SRL Revenue in Liposome Technology Service Business (2020-2025)
11.10.5 LIPOMIZE SRL Recent Development
11.11 Maison KOS脡
11.11.1 Maison KOS脡 Company Details
11.11.2 Maison KOS脡 Business Overview
11.11.3 Maison KOS脡 Liposome Technology Service Introduction
11.11.4 Maison KOS脡 Revenue in Liposome Technology Service Business (2020-2025)
11.11.5 Maison KOS脡 Recent Development
11.12 Microfluidics International Corporation
11.12.1 Microfluidics International Corporation Company Details
11.12.2 Microfluidics International Corporation Business Overview
11.12.3 Microfluidics International Corporation Liposome Technology Service Introduction
11.12.4 Microfluidics International Corporation Revenue in Liposome Technology Service Business (2020-2025)
11.12.5 Microfluidics International Corporation Recent Development
11.13 Exelead
11.13.1 Exelead Company Details
11.13.2 Exelead Business Overview
11.13.3 Exelead Liposome Technology Service Introduction
11.13.4 Exelead Revenue in Liposome Technology Service Business (2020-2025)
11.13.5 Exelead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

LIPOSOMA
CD Formulation
Creative Biostruct
Echelon Biosciences
Encapsula Nanosciences
Toshiba
FUJIFILM Pharmaceuticals USA
Lifeasible
PlantaCorp
LIPOMIZE SRL
Maison KOS脡
Microfluidics International Corporation
Exelead

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂